Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and lymphatic tissue (mesenchymal cells). Despite being widely ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss ... serious complications of liver disease and an 80% lower risk of progression to ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections ... lead to kidney injury, low blood pressure and falls. In individuals with advanced chronic kidney disease, clinicians may ...

Even so, this relatively lean state had among the nation’s biggest surges last year in residents taking blockbuster weight-loss drugs, and the trend shows no signs of abating. About 140,400 ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study. For several decades, researchers studying Alzheimer's disease have been working to ...

“These drugs also reduce inflammation in the brain and result in weight loss; both these factors may improve brain health and explain the reduced risk of conditions like Alzheimer’s disease ...

Plus, with no more than 14 grams of carbohydrates and at least 15 grams of protein per serving, these dishes are satisfying choices to help keep you energized while meeting your nutrition goals.

AT2 dysfunction underlies many lung diseases, including interstitial lung disease (ILD), in which some inherited forms result from the mislocalization of surfactant protein C (SFTPC ... to investigate ...

The study is among the first to show that the rotavirus protein NSP4 is both necessary ... These disruptions in calcium signaling affect rotavirus disease severity, providing new insights into ...